{"id":"67826544528-01","name":"Grünenthal GmbH","registrationDate":"2010-11-14T18:46:49.326+01:00","category":2,"subCategory":3,"legal":"Gesellschaft mit beschränkter Haftung","web":"http://www.grunenthal.com","country":"Germany","headAddress":"Zieglerstraße, 6","headCity":"Aachen","headPostCode":"D-52099","headPhone":"(49)2 41 56 90","boss":"Gabriel Baertschi","bossTitle":"Mr","bossPosition":"Chairman of the Corporate Executive Board","membersCount":2,"membersFTE":"0.75","membership":"Grünenthal is a member of the European Federation of Pharmaceutical Industries and Associations (EFPIA): http://www.efpia.eu&#xd;\n&#xd;\nGrünenthal supports the platform the Societal Impact of Pain (SIP). More info can be found here: https://www.sip-platform.eu","memberOrga":"","goal":"The Grünenthal Group is an entrepreneurial, science-based pharmaceutical company specialized in pain, gout and inflammation.&#xd;<br />Our ambition is to deliver four to five new products to patients in diseases with high unmet medical need by 2022 and become a €2 billion company.&#xd;<br />We are a fully integrated research &amp; development company with a long track record of bringing innovative pain treatments and state-of-the-art technologies to patients. By sustainably investing in our R&amp;D above the industrial average, we are strongly committed to innovation.&#xd;<br />Grünenthal is an independent, family-owned company headquartered in Aachen, Germany. We are present in 32 countries with affiliates in Europe, Latin America and the US. Our products are sold in more than 155 countries and approx. 5,500 employees are working for the Grünenthal Group worldwide. In 2016, Grünenthal achieved revenues of approx. € 1.4 bn.&#xd;<br />&#xd;<br />More information: www.grunenthal.com","acronym":"Grünenthal","interests":"Competition, Economic and Financial Affairs, Employment and Social Affairs, General and Institutional Affairs, Humanitarian Aid, Information Society, Internal Market, Public Health, Regional Policy, Research and Technology","euInitiatives":"Grünenthal interests in Brussels deal with issues related to health- and pain care, pharmaceuticals, innovation, research and intellectual property.","lastUp":"2018-02-21T10:39:04.203+01:00","customers":"","costAbsolu":"","costRange":"300000-399999","turnoverAbsolu":0,"turnoverRange":""}